Author:
Bobak Carly A.,Stevenson Keisean A. J. M.,Sun Ning,Khan Mohammad S.,Azmir Jannatul,Beccaria Marco,Tomko Jaime A.,Fillmore Daniel,Scanga Charles A.,Lin Philana L.,Flynn JoAnne L.,Hill Jane E.
Abstract
AbstractNon-human primates remain the most useful and reliable pre-clinical model for many human diseases. Primate breath profiles have previously distinguished healthy animals from diseased, including non-human primates. Breath collection is relatively non-invasive, so this motivated us to define a healthy baseline breath profile that could be used in studies evaluating disease, therapies, and vaccines in non-human primates. A pilot study, which enrolled 30 healthy macaques, was conducted. Macaque breath molecules were sampled into a Tedlar bag, concentrated onto a thermal desorption tube, then desorbed and analyzed by comprehensive two-dimensional gas chromatography-time of flight mass spectrometry. These breath samples contained 2,017 features, of which 113 molecules were present in all breath samples. The core breathprint was dominated by aliphatic hydrocarbons, aromatic compounds, and carbonyl compounds. The data were internally validated with additional breath samples from a subset of 19 of these non-human primates. A critical core consisting of 23 highly abundant and invariant molecules was identified as a pragmatic breathprint set, useful for future validation studies in healthy primates.
Funder
Burroughs Wellcome Fund
The Bill and Melinda Gates Foundation
National Institutes of Health
Publisher
Springer Science and Business Media LLC